Research Brings 'Effective' Hepatitis C Cure Close to Reality

Scientists have determined the most detailed picture, yet of a crucial part of the hepatitis C virus, which the virus uses to infect the liver cells.

The study by the scientists at the Scripps Research Institute (TSRI), focuses on a protein- known as E2 envelope glycoprotein and reveals unexpected structural features of this protein and should greatly speed efforts to make an effective hepatitis C vaccine.

Hepatitis C - Causes, Symptoms, Diagnosis, Treatment, Complications, Prevention
Hepatitis C is a contagious viral disease affecting the liver that is caused by the hepatitis C virus.

Any successful hepatitis C vaccine is likely to target the E2 protein. Scientists already have isolated rare antibodies from patients that can bind E2 in ways that neutralize a broad range of viral strains.

"Usually if you try to express the E2 protein in cultured cells, you either can't express it in useful quantities or you can but it aggregates and becomes a big mess," lead author Leopold Kong, a research associate in the Wilson laboratory, said.

The study is published in the journal Science.

Protection Against Hepatic Injury Caused by Hepatitis C and Alcohol Provided by Transcription Factor
The transcription factor FOXO3 may protect against alcohol-induced liver injury, according to a new study.

Source-ANI

Study Suggests Pregnant Women With Hepatitis C may Pass Heartier Viral Strain to Newborn
Anew study has found that infants who get hepatitis C from their mothers during childbirth may inherit a viral strain that replicates more quickly than strains found in non-pregnant hosts.

Canada is in Need of a National Screening Strategy for Hepatitis C
A group of liver specialists in the Toronto Western Hospital Francis Family Liver Clinic say that Canada should begin screening 'Baby Boomers' for the hepatitis C virus.